Insmed (INSM) Equity Ratio (2010 - 2026)

Insmed's Equity Ratio history runs 17 years deep, the most recent figure standing at 0.34 for Q1 2026.

• In Q1 2026, Equity Ratio rose 517.3% year-over-year to 0.34; the TTM figure through Mar 2026 stood at 0.34 (up 517.3% YoY), while the FY2025 annual figure was 0.33, up 131.58% from the prior year.
• Equity Ratio was 0.34 for Q1 2026 at Insmed, up from 0.33 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.5 in Q2 2025 to a low of 0.4 in Q1 2024.
• Historically, Equity Ratio has averaged 0.07 across 5 years, with a median of 0.05 in 2022.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio tumbled 1263.0% in 2024, then surged 2249.98% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.05 in 2022, then tumbled by 570.08% to 0.25 in 2023, then jumped by 156.46% to 0.14 in 2024, then surged by 131.58% to 0.33 in 2025, then advanced by 4.05% to 0.34 in 2026.
• The last three Equity Ratio figures came in at 0.34 (Q1 2026), 0.33 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.